1. Academic Validation
  2. The antiacetylcholinesterase and antileishmanial activities of Canarium patentinervium Miq

The antiacetylcholinesterase and antileishmanial activities of Canarium patentinervium Miq

  • Biomed Res Int. 2014;2014:903529. doi: 10.1155/2014/903529.
R Mogana 1 A Adhikari 2 S Debnath 3 S Hazra 3 B Hazra 3 K Teng-Jin 1 C Wiart 1
Affiliations

Affiliations

  • 1 School of Pharmacy, Faculty of Science, Center for Natural and Medicinal Products Research, University of Nottingham (Malaysia Campus), Jalan Broga, 43500 Semenyih, Selangor, Malaysia.
  • 2 HEJ Research Institute of Chemistry, University of Karachi, Karachi 75270, Pakistan.
  • 3 Department of Pharmaceutical Technology, Jadavpur University Calcutta, West Bengal 700032, India.
Abstract

In continuation of our natural and medicinal research programme on tropical rainforest Plants, a bioassay guided fractionation of ethanolic extract of leaves of Canarium patentinervium Miq. (Burseraceae Kunth.) led to the isolation of scopoletin (1), scoparone (2), (+)-catechin (3), vomifoliol (4), lioxin (5), and syringic acid (6). All the compounds exhibited antiacetylcholinesterase activity with syringic acid, a phenolic acid exhibiting good AChE inhibition (IC50 29.53 ± 0.19 μ g/mL). All compounds displayed moderate antileishmanial activity with scopoletin having the highest antileishmanial activity (IC50 163.30 ± 0.32 μ g/mL). Given the aforementioned evidence, it is tempting to speculate that Canarium patentinervium Miq. represents an exciting scaffold from which to develop leads for treatment of neurodegenerative and parasitic diseases.

Figures
Products